1. Oze I, Matsuo K, Hosono S, et al. Comparison between self-
reported facial flushing after alcohol consumption and ALDH2
Glu504Lys polymorphism for risk of upper aerodigestive tract
cancer in a Japanese population. Cancer Sci. 2010;101(8):1875-
1880. doi:10.1111/j.1349-7006.2010.01599.x
2. Koyanagi YN, Suzuki E, Imoto I, et al. Across-site differences
in the mechanism of alcohol-induced digestive tract carcinogenesis: an evaluation by mediation analysis. Cancer Res.
2020;80(7):1601-1610. doi:10.1158/0008-5472.can-19-2685
3. Ugai T, Milne RL, Ito H, et al. The functional ALDH2 polymorphism is associated with breast cancer risk: a pooled analysis
from the Breast Cancer Association Consortium. Mol Gen
Genom Med. 2019;7(6):e707. doi:10.1002/mgg3.707
4. Shen X, Wang R, Kim MJ, et al. A surge of DNA damage
links transcriptional reprogramming and hematopoietic deficit in fanconi anemia. Mol Cell. 2020;80(6):1013-1024.e6.
doi:10.1016/j.molcel.2020.11.040
5. Wang M, Dingler FA, Patel KJ. Genotoxic aldehydes in the hematopoietic system. Blood. 2022;139:2119-2129. doi:10.1182/
blood.2019004316
6. Tacconi EM, Lai X, Folio C, et al. BRCA1 and BRCA2 tumor
suppressors protect against endogenous acetaldehyde toxicity. EMBO Mol Med. 2017;9(10):1398-1414. doi:10.15252/
emmm.201607446
7. Yang Z, Wu XS, Wei Y, et al. Transcriptional silencing of
ALDH2 confers a dependency on fanconi anemia proteins in
acute myeloid leukemia. Cancer Discov. 2021;11(9):2300-2315.
doi:10.1158/2159-8290.cd-20-1542
8. Ceccaldi R, Sarangi P, D'Andrea AD. The Fanconi anaemia
pathway: new players and new functions. Nat Rev Mol Cell Biol.
2016;17(6):337-349. doi:10.1038/nrm.2016.48
9. Hira A, Yabe H, Yoshida K, et al. Variant ALDH2 is associated with accelerated progression of bone marrow failure in
Japanese Fanconi anemia patients. Blood. 2013;122(18):3206-
3209. doi:10.1182/blood-2013-06-507962
10. King MC, Marks JH, Mandell JB, Group NYBCS. Breast and
ovarian cancer risks due to inherited mutations in BRCA1 and
BRCA2. Science. 2003;302(5645):643-646. doi:10.1126/science.
1088759
11. Inagaki-Kawata Y, Yoshida K, Kawaguchi-Sakita N,
et al. Genetic and clinical landscape of breast cancers with
germline BRCA1/2 variants. Commun Biol. 2020;3(1):578-579.
doi:10.1038/s42003-020-01301-9
12. Prakash R, Zhang Y, Feng W, Jasin M. Homologous recombination and human health: the roles of BRCA1, BRCA2,
and associated proteins. Cold Spring Harb Perspect Biol.
2015;7(4):a016600. doi:10.1101/cshperspect.a016600
13. Tan SLW, Chadha S, Liu Y, et al. A class of environmental and
endogenous toxins induces BRCA2 haploinsufficiency and genome instability. Cell. 2017;169(6):1105-1118.e15. doi:10.1016/j.
cell.2017.05.010
14. Matsuo K, Wakai K, Hirose K, Ito H, Saito T, Tajima K.
Alcohol dehydrogenase 2 His47Arg polymorphism influences
drinking habit independently of aldehyde dehydrogenase 2
Glu487Lys polymorphism: analysis of 2,299 Japanese subjects. Cancer Epidemiol Biomarkers Prev. 2006;15(5):1009-1013.
doi:10.1158/1055-9965.epi-05-0911
20457634, 2023, 6, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/cam4.5430 by Cochrane Japan, Wiley Online Library on [25/10/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
MORI et al.
15. Arai M, Yokoyama S, Watanabe C, et al. Genetic and clinical
characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan. J Hum Genet. 2018;63(4):447-457. doi:10.1038/
s10038-017-0355-1
16. Tye S, Ronson GE, Morris JR. A fork in the road: where homologous recombination and stalled replication fork protection
part ways. Semin Cell Dev Biol. 2021;113:14-26. doi:10.1016/j.
semcdb.2020.07.004
17. Daniele A, Divella R, Pilato B, et al. Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in
BRCA 1 and BRCA 2 mutation carriers? A Mini review. Hered
Cancer Clin Pr. 2021;19(1):45. doi:10.1186/s13053-021-00199-6
18. Mu A, Hira A, Niwa A, et al. Analysis of disease model iPSCs
derived from patients with a novel Fanconi anemia-like IBMFS
ADH5/ALDH2 deficiency. Blood. 2021;137(15):2021-2032.
doi:10.1182/blood.2020009111
19. Dingler FA, Wang M, Mu A, et al. Two aldehyde clearance
systems are essential to prevent lethal formaldehyde accumulation in mice and humans. Mol Cell. 2020;80(6):996-1012.e9.
doi:10.1016/j.molcel.2020.10.012
MORI et al.
20. Marcato P, Dean CA, Pan D, et al. Aldehyde dehydrogenase
activity of breast cancer stem cells is primarily due to isoform
ALDH1A3 and its expression is predictive of metastasis. Stem
Cells. 2011;29(1):32-45. doi:10.1002/stem.563
SUPPORTING INFORMATION
Additional supporting information can be found online
in the Supporting Information section at the end of this
article.
How to cite this article: Mori T, Okamoto Y, Mu
A, et al. Lack of impact of the ALDH2 rs671 variant
on breast cancer development in Japanese
BRCA1/2-mutation carriers. Cancer Med.
2023;12:6594-6602. doi: 10.1002/cam4.5430
20457634, 2023, 6, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/cam4.5430 by Cochrane Japan, Wiley Online Library on [25/10/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
6602 ...